Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BLISS GVS PHARMA Plunges 10%; BSE HEALTHCARE Index Up 0.6%
Fri, 25 Oct 9:28

BLISS GVS PHARMA Plunges 10%; BSE HEALTHCARE Index Up 0.6%Image source: ipopba/www.istockphoto.com

BLISS GVS PHARMA share price has plunged 10% and is presently trading at Rs 111.9.

Meanwhile, the BSE HEALTHCARE index is at 43,143.5 (up 0.6%).

Among the top losers in the BSE HEALTHCARE index today are Procter & Gamble Health (down 2.1%) and CAPLIN POINT (down 1.1%).

LAURUS LABS (up 2.8%) and ASTER DM HEALTHCARE (up 2.5%) are among the top gainers today.

Over the last one year, BLISS GVS PHARMA has moved up from Rs 82.5 to Rs 111.9, registering a gain of Rs 29.4 (up 35.6%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,503.7 to 43,143.5, registering a gain of 56.9% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 206.8%), Glenmark Pharma (up 123.9%) and SUVEN PHARMACEUTICALS (up 123.2%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 80,109.2 (up 0.1%).

The top gainers among the BSE Sensex today are ITC (up 3.3%) and Axis Bank (up 2.5%). The most traded stocks in the BSE Sensex are Indusind Bank and ITC.

In the meantime, NSE Nifty is at 24,393.2 . Indusind Bank and NTPC are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,571.9 to 80,109.2, registering a gain of 15,537.3 points (up 24.1%).

BLISS GVS PHARMA Financial Update...

BLISS GVS PHARMA net profit grew 53.8% YoY to Rs 221 million for the quarter ended June 2024, compared to a profit of Rs 144 million a year ago. Net sales rose 15.1% to Rs 1,836 million during the period as against Rs 1,595 million in April-June 2023.

For the year ended March 2024, BLISS GVS PHARMA reported 6.3% increase in net profit to Rs 816 million compared to net profit of Rs 767 million during FY23. Revenue of the company grew 2.5% to Rs 7,702 million during FY24.

The current Price to earnings ratio of BLISS GVS PHARMA, based on rolling 12 month earnings, stands at 13.2.


Equitymaster requests your view! Post a comment on "BLISS GVS PHARMA Plunges 10%; BSE HEALTHCARE Index Up 0.6%". Click here!